Key Takeaways FDA has launched an aggressive new crackdown on direct-to-consumer (DTC) drug advertising, issuing nearly 100 cease-and-desist letters and thousands of notices — many targeting ...

Vor Biopharma has rebounded from near-delisting by securing global rights (ex-China) to telitacicept, a promising autoimmune therapy. Click here to read more.

While the current freight market has excess capacity, actions taken now are setting the stage for a severe driver shortage.

The Trump administration’s crackdown on pharmaceutical ads is a welcome step toward lessening Big Pharma’s influence over ...

A complex state vs. federal regulatory scheme allows drug compounders to advertise drugs without disclosing risks like a ...

Germany-headquartered technology giant Merck has set its sights on becoming the "best partner of choice" in the ...

Quotient Sciences, a UK and US-based drug product formulation and manufacturing company, offers flexible, phase-appropriate development and scale-up at our fully FDA-compliant and globally-inspected ...

An effort by President Trump’s administration to curb advertising for pharmaceutical drugs on television is posing a potential marketing hurdle for some of the country’s largest drugmakers while ...

On top of that, drug ads must provide “fair balance,” meaning the positives and negatives have to both be presented. In ...